Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study

By Isik AZ   Caglar GS   Sozen E   Akarsu C   Tuncay G   Ozbıcer T   Vicdan K  

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 472-477

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS

By Aboulghar Mohamed A   Mansour Ragaa T   Amin Yahia M   Al-Inany Hesham G   Aboulghar Mona M   Serour Gamal I  

Reproductive BioMedicine Online, Vol. 15, Iss. 3, 2007-09 ,pp. : 271-279

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocol

By Lainas TG   Sfontouris IA   Zorzovilis IZ   Petsas GK   Lainas GT   Iliadis GS   Kolibianakis EM  

Reproductive BioMedicine Online, Vol. 18, Iss. 1, 2009-01 ,pp. : 15-20

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Case Report: Achievement of pregnancy three times in the same patient during luteal GnRH agonist administration

By Papanikolaou Evangelos G   Platteau Peter   Albano Carola   Kolibianakis Efstratios   Devroey Paul  

Reproductive BioMedicine Online, Vol. 10, Iss. 3, 2005-03 ,pp. : 347-349

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Luteal phase characteristics following GnRH antagonist or agonist treatment – a comparative study

By Friedler Shevach   Gilboa Sarit   Schachter Morey   Raziel Arieh   Strassburger Devorah   Ron El Raphael  

Reproductive BioMedicine Online, Vol. 12, Iss. 1, 2006-01 ,pp. : 27-32

Reproductive Healthcare Ltd

Access to resources Recommend Favorite